Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026 
Sinaloa Governor Ruben Rocha Denies U.S. Cartel Allegations, Calls Charges Political 
Coinbase Q1 2026 Earnings Miss Sends COIN Stock Lower Amid Crypto Market Slump 
Trump Administration Files Fraud Charges Against Southern Poverty Law Center Over Informant Payments 
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 
Kuaishou Stock Jumps on Kling AI IPO Plans and $20 Billion Valuation 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
DOJ Ends Probe Into Fed Chair Jerome Powell, Boosting Kevin Warsh Confirmation Prospects 
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 
Judge Orders Release of Family After Longest ICE Detention Under Trump Administration 
OCBC Q1 Profit Rises 5% on Strong Wealth Management and Non-Interest Income 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
US Trade Court Blocks Trump’s 10% Global Tariffs 
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes 
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO 
Chemours, Dupont De Nemours, and Corteva have announced a $110 million settlement with the U.S. state of Ohio to resolve claims linked to toxic "forever chemicals." This agreement aims to address concerns surrounding per- and polyfluoroalkyl substances (PFAS).
Nasdaq reported that the chemical has been associated with various health risks. The settlement covers costs related to the release of PFAS from the companies' facilities, including the Washington Works site situated along the Ohio-West Virginia border, as per Reuters.
Responsibility Distribution for Settlement Costs
According to the agreement, Chemours, a spin-off of DuPont, will bear 50% of the settlement costs, while DuPont will contribute approximately $39 million. Corteva, on the other hand, is expected to cover the remaining expenses. The resolution brings an end to Ohio's claims concerning the release of PFAS, affording the state an opportunity to address this issue comprehensively.
The resolution of the Ohio settlement emphasizes the importance of addressing the wide-reaching implications of PFAS contamination.
Notably, the settlement between the companies and Ohio has triggered a contingency provision outlined in Delaware's 2021 PFAS settlement with the same entities.
This provision requires an additional payment of $25 million to the state of Delaware and the original $50 million settlement if a similar agreement is reached within eight years with another state, amounting to over $50 million. This provision underlines the accountability held by chemical manufacturers in addressing the concerns associated with PFAS contamination.
Legal Battles Surrounding PFAS
Chemical manufacturers have faced numerous lawsuits in recent years regarding alleged PFAS contamination. In a significant ruling, a U.S. appeals court rejected a lower court's decision that would have allowed approximately 11.8 million Ohio residents to sue 10 PFAS manufacturers as a collective group. The legal landscape demonstrates the complexity surrounding PFAS-related claims and the efforts to hold responsible parties accountable for their actions.
In June, 3M agreed to a $10.3 billion settlement to address hundreds of claims alleging the company had contaminated public drinking water with PFAS. Similarly, Chemours, DuPont, and Corteva reached a separate settlement with U.S. water providers, amounting to $1.19 billion.
These settlements underscore the growing recognition within the industry regarding the need to address PFAS-related concerns and the responsibility manufacturers bear in ensuring the safety of their products and practices.
Photo: DuPont Newsroom
